TARDBP and amyotrophic lateral sclerosis: The effects of edaravone on endogenous and spontaneous TDP-43 pathology should be addressed in the future using neuronal cells derived from induced pluripotent stem cells or neural stem cells of human origin harboring mutations associated with ALS.